Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $705,432 - $848,671
-4,849 Reduced 72.96%
1,797 $299,000
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $25,703 - $30,864
196 Added 3.04%
6,646 $974,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $956,470 - $1.18 Million
6,450 New
6,450 $956,000
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $246,077 - $272,597
-1,300 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $202,670 - $244,387
1,300 New
1,300 $242,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.